{
    "2019-01-09": [
        [
            {
                "time": "",
                "original_text": "华大基因：监事及核心骨干人员增持计划完成，共买入1073万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "监事",
                        "核心骨干",
                        "增持计划",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因大股东几乎质押所有持股",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大股东",
                        "质押",
                        "持股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}